Asthma

The approval is based on data from a phase 3 placebo-controlled trial that evaluated the efficacy and safety of dupilumab combined with standard-of-care therapy in children with uncontrolled moderate-to-severe asthma.

PT0271 improved lung function and reduced the risk of exacerbations in individuals with asthma.

A new study explores why individuals who suffer most from the condition have the worse symptoms at night.

Study indicates that patients with asthma should continue taking their asthma medications during the COVID-19 pandemic.

Inspiratory muscle training was originally devised to be used by athletes and individuals with breathing problems such as chronic obstructive pulmonary disease, asthma, and bronchitis.

Severe persistent asthma is the worse type of asthma.

Both asthma and chronic obstructive pulmonary disease cause swelling in the airways that makes it difficult to breathe.

Include pediatric patients in demonstrations and discussions to improve outcomes.

The FDA also granted Breakthrough Therapy Designation to tezepelumab for patients with severe asthma without an eosinophilic phenotype in September 2018.

A 300 mg dose is currently available with a prescription.

Study indicates that teens and adults who use e-cigarettes have increased odds of developing asthma and having asthma attacks.

Patients who added dupilumab to standard of care saw a 65% reduction in the rate of severe asthma attacks over 1 year.

Pharmacists should counsel patients periodically to ensure correct usage for better disease and treatment management.

Blood eosinophil counts and FeNO levels are 2 key inflammatory biomarkers used by clinicians to inform treatment options and were defined as blood eosinophil count and FeNO.

Supplies of the critical rescue medication for asthma attacks were close to depleted at many hospitals amid COVID-19.

Pharmacists can play a direct role in addressing social disparities of health in low-income communities by building trust and providing expertise to patients.

Pharmacists can play a vital role by offering inhaler counseling and helping improve adherence, especially during COVID-19.

This is the first study to demonstrate air pollution as a driver of the most challenging type of asthma to treat, the severe non-Th2 subtype, which is non-responsive to current therapies.

With allergy season under way, pharmacists can help patients identify triggers and coach them on how to manage.

Researchers in Australia analyzed data from 57 studies with an overall sample size of 587,280 individuals. Approximately 350,000 people in the pool had been infected with COVID-19 from Asia, Europe, and North and South America.

Medications can play an important role in asthma management. Therefore, adherence to medications is important to optimize treatment and improve quality of life.

Inhalation therapy is reliant upon correct inhaler technique to allow for optimal deposition of medication.

In the midst of the COVID-19 pandemic, it is important that individuals who are at higher risk for poor outcomes from infection with vaccine-preventable diseases remain up-to-date with their immunizations.

Smart inhalers have the potential to address the challenges faced by patients and health care professionals in the management of respiratory diseases.

Those wearing a facemask while exercising may feel an increased sensation of dyspnea, however, there is little evidence that this medical condition is occurring.

Frequent or chronic use of oral corticosteroids can lead to serious adverse effects in patients with asthma, including weight gain, diabetes, immunosuppression, and adrenal insufficiency.

Digital health tools were a major theme during the first-ever NASP Challenge, comprising 4 of the 5 finalists.

The triple combination therapy is the first single inhaler triple therapy approved for both asthma and COPD and is the only single inhaler triple therapy available as a once-daily inhalation.

Contrary to earlier statements from the CDC, study suggests corticosteroid inhalers used by many asthmatics might make it more difficult for COVID-19 to enter the airways.

New research contradicts previous observational studies on the effect of vitamin D supplements in severe asthma prevention.